181 related articles for article (PubMed ID: 23184530)
1. Regulation of primitive hematopoiesis by class I histone deacetylases.
Shah RR; Koniski A; Shinde M; Blythe SA; Fass DM; Haggarty SJ; Palis J; Klein PS
Dev Dyn; 2013 Feb; 242(2):108-21. PubMed ID: 23184530
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylases are required for amphibian tail and limb regeneration but not development.
Taylor AJ; Beck CW
Mech Dev; 2012; 129(9-12):208-18. PubMed ID: 22947425
[TBL] [Abstract][Full Text] [Related]
3. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats.
Bogaard HJ; Mizuno S; Hussaini AA; Toldo S; Abbate A; Kraskauskas D; Kasper M; Natarajan R; Voelkel NF
Am J Respir Crit Care Med; 2011 May; 183(10):1402-10. PubMed ID: 21297075
[TBL] [Abstract][Full Text] [Related]
4. Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos.
Li X; Jia S; Wang S; Wang Y; Meng A
Blood; 2009 Dec; 114(27):5464-72. PubMed ID: 19864643
[TBL] [Abstract][Full Text] [Related]
5. A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons.
Fujiki R; Sato A; Fujitani M; Yamashita T
Cell Death Dis; 2013 Jun; 4(6):e677. PubMed ID: 23788034
[TBL] [Abstract][Full Text] [Related]
6. HDAC activity is required during Xenopus tail regeneration.
Tseng AS; Carneiro K; Lemire JM; Levin M
PLoS One; 2011; 6(10):e26382. PubMed ID: 22022609
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.
Fortson WS; Kayarthodi S; Fujimura Y; Xu H; Matthews R; Grizzle WE; Rao VN; Bhat GK; Reddy ES
Int J Oncol; 2011 Jul; 39(1):111-9. PubMed ID: 21519790
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of histone deacetylases class I improves adipogenic differentiation of human periodontal ligament cells.
Serralta-Interian AA; Montero Del Toro J; Nic-Can GI; Rojas-Herrera R; Aguilar-Ayala FJ; Rodas-Junco BA
Cell Mol Biol (Noisy-le-grand); 2024 May; 70(5):40-47. PubMed ID: 38814236
[TBL] [Abstract][Full Text] [Related]
9. Effects of histone deacetylase inhibitors on regenerative cell responses in human dental pulp cells.
Luo Z; Wang Z; He X; Liu N; Liu B; Sun L; Wang J; Ma F; Duncan H; He W; Cooper P
Int Endod J; 2018 Jul; 51(7):767-778. PubMed ID: 28375564
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
Foti SB; Chou A; Moll AD; Roskams AJ
Int J Dev Neurosci; 2013 Oct; 31(6):434-47. PubMed ID: 23542004
[TBL] [Abstract][Full Text] [Related]
12. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo.
Gurvich N; Berman MG; Wittner BS; Gentleman RC; Klein PS; Green JB
FASEB J; 2005 Jul; 19(9):1166-8. PubMed ID: 15901671
[TBL] [Abstract][Full Text] [Related]
13. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation.
Shin HJ; DeCotiis J; Giron M; Palmeri D; Lukac DM
J Virol; 2014 Jan; 88(2):1281-92. PubMed ID: 24227836
[TBL] [Abstract][Full Text] [Related]
15. Differential response of cancer cells to HDAC inhibitors trichostatin A and depsipeptide.
Chang J; Varghese DS; Gillam MC; Peyton M; Modi B; Schiltz RL; Girard L; Martinez ED
Br J Cancer; 2012 Jan; 106(1):116-25. PubMed ID: 22158273
[TBL] [Abstract][Full Text] [Related]
16. Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs.
Eisses JF; Criscimanna A; Dionise ZR; Orabi AI; Javed TA; Sarwar S; Jin S; Zhou L; Singh S; Poddar M; Davis AW; Tosun AB; Ozolek JA; Lowe ME; Monga SP; Rohde GK; Esni F; Husain SZ
Am J Pathol; 2015 Dec; 185(12):3304-15. PubMed ID: 26476347
[TBL] [Abstract][Full Text] [Related]
17. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: role of inhibition of histone deacetylases?
Hoffmann K; Czapp M; Löscher W
Epilepsy Res; 2008 Oct; 81(2-3):107-13. PubMed ID: 18538545
[TBL] [Abstract][Full Text] [Related]
18. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
Menegola E; Di Renzo F; Broccia ML; Prudenziati M; Minucci S; Massa V; Giavini E
Birth Defects Res B Dev Reprod Toxicol; 2005 Oct; 74(5):392-8. PubMed ID: 16193500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
